Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide.
about
Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processesIncreased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathwaysLactosylceramide contributes to mitochondrial dysfunction in diabetesThe compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.Roles of Sphingolipid Metabolism in Pancreatic β Cell Dysfunction Induced by Lipotoxicity.Exercise-induced cardiac performance in autoimmune (type 1) diabetes is associated with a decrease in myocardial diacylglycerol.Mechanisms of lipotoxicity in the cardiovascular system.High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphateTargeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.Risk of death in heart disease is associated with elevated urinary globotriaosylceramide.Creating and curing fatty hearts.The twists and turns of sphingolipid pathway in glucose regulationLipotoxicity in type 2 diabetic cardiomyopathy.Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease.Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.Lipotoxicity in Obesity: Benefit of Olive Oil.Eat and Death: Chronic Over-Eating.Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.Serum Metabolomics of Activity Energy Expenditure and its Relation to Metabolic Syndrome and Obesity.Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.
P2860
Q27022944-F77EA67F-8E7B-4022-97FF-9F7EF12815D0Q28385804-731751D4-9C8B-4040-9B58-CCBFF660FA04Q28390671-3CCA86E1-1091-4FC5-A1AD-C35F84948915Q30578060-C14A6735-465C-4E8C-A8AC-83153C169C19Q35667288-A9C6D93A-3294-4625-98FF-734A3B3B2352Q36320842-7A07C4DF-0427-4B39-B910-CFB71C8C3EFDQ36377252-C762DDCA-907B-4FA0-8F38-A828D979A94BQ36691031-85557D87-79B4-4233-A309-0398B9B3F77DQ36868420-7A11960D-1181-4B0C-BFAB-E9DE827B9831Q37457580-F989CCAB-76FE-4387-A722-C7370BE1BFB1Q37648595-6BB554AF-B004-4C3A-986A-0037FD902770Q37654267-0991A20C-E766-4C34-B860-F33D2910A915Q37766367-14B2C3AF-5B58-489B-A923-A976FAEB3351Q37908843-B5F93CBD-9460-4D68-93C5-85915CEB6F5AQ38034934-E48B28B0-3EDC-4656-84F6-35CE4B5AB31BQ38045551-A591B691-8D2F-4752-819C-7387AEF36A53Q38937414-E74DFE18-96D4-4873-96F6-1A1F264531C9Q39353777-86F475D2-B688-462B-9556-B677CD438F6FQ40171362-508D05FC-4E60-4995-BE5B-59D407E871CAQ41813859-ACAC6D5C-6CD1-47EE-AA5C-74CBFD4E9D0EQ49830624-5D16D5EE-148E-4570-BCA4-AE1850E2FD30Q55278796-186E52B3-0612-483C-BA97-6CF8E3F5AF4F
P2860
Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myocardium of type 2 diabetic ...... t by accumulation of ceramide.
@en
Myocardium of type 2 diabetic ...... t by accumulation of ceramide.
@nl
type
label
Myocardium of type 2 diabetic ...... t by accumulation of ceramide.
@en
Myocardium of type 2 diabetic ...... t by accumulation of ceramide.
@nl
prefLabel
Myocardium of type 2 diabetic ...... t by accumulation of ceramide.
@en
Myocardium of type 2 diabetic ...... t by accumulation of ceramide.
@nl
P2860
P50
P1476
Myocardium of type 2 diabetic ...... ot by accumulation of ceramide
@en
P2093
Dorota Harasiuk
Piotr Zabielski
P2860
P356
10.1194/JLR.M900002-JLR200
P50
P577
2010-01-01T00:00:00Z